Home/Client Communications/Apellis seeking approval for pegcetacoplan Apellis seeking approval for pegcetacoplan February 8, 2023 Intravitreal pegcetacoplan would be the first FDA-approved treatment for geographic atrophy (GA) secondary to age-related macular degeneration.